DUBLIN--(BUSINESS WIRE)--The 'Global Multimodal Imaging Market - Outlook & Forecast 2024-2029' report has been added to ResearchAndMarkets.com's offering.

都柏林——（商业新闻短讯）——ResearchAndMarkets.com的产品中增加了“2024-2029年全球多模式成像市场展望与预测”报告。

The global multimodal imaging market is expected to reach a value of $5.5 billion by 2029 from $4.02 billion in 2023, growing at a CAGR of 5.35% from 2023-2029

预计到2029年，全球多模式成像市场的价值将从2023年的40.2亿美元达到55亿美元，2023-2029年的复合年增长率为5.35%

The global multimodal imaging market is a dynamic and fiercely competitive landscape driven by technological advancements, increasing demand for precise diagnostic solutions, and a growing emphasis on personalized healthcare. The global multimodal imaging market is dominated by several key players, each with a significant industry presence and a diverse portfolio of imaging solutions..

全球多模式成像市场是一个动态且竞争激烈的领域，技术进步，对精确诊断解决方案的需求不断增加，以及对个性化医疗保健的日益重视。全球多模式成像市场由几个关键参与者主导，每个参与者都有重要的行业存在和多样化的成像解决方案组合。。

Some of the leading players in the market include Canon Medical Systems, GE Healthcare, Koninklijke Philips, Siemens Healthineers, and Shimadzu Corporation. Furthermore, leading players invest heavily in research and development to drive innovation in multimodal imaging technologies. This includes developing advanced imaging systems with enhanced capabilities such as AI-driven image analysis, real-time image fusion, and 3D/4D imaging..

市场上的一些主要参与者包括佳能医疗系统、通用电气医疗保健公司、Koninklijke Philips、西门子Healthineers和岛津公司。此外，主要参与者在研究和开发方面投入巨资，以推动多模式成像技术的创新。这包括开发具有增强功能的高级成像系统，例如AI驱动的图像分析，实时图像融合和3D/4D成像。。

North America, particularly the US and Canada, dominates the global multimodal imaging market due to well-established healthcare infrastructure, high healthcare spending, and early adoption of advanced medical technologies. The presence of major multinational healthcare companies, research institutions, and academic centers drives innovation and market growth in this region..

北美，特别是美国和加拿大，由于完善的医疗基础设施，高昂的医疗支出以及先进医疗技术的早期采用，在全球多模式成像市场上占据主导地位。大型跨国医疗保健公司、研究机构和学术中心的存在推动了该地区的创新和市场增长。。

The demand for multimodal imaging in the region is fueled by the prevalence of chronic diseases, the aging population, an increasing emphasis on early disease detection, and personalized medicine.

慢性病的流行，人口老龄化，对早期疾病检测的日益重视以及个性化医疗，推动了该地区对多模式成像的需求。

Growing Adoption of AI & Analytics in Diagnostic Imaging

人工智能和分析技术在诊断成像中的应用日益广泛

The growing adoption of AI and analytics in diagnostic imaging undoubtedly creates exciting opportunities for the multimodal imaging market. By unlocking the power of complex data, AI has the potential to transform the way we diagnose and treat diseases, leading to improved patient outcomes and a more efficient healthcare system.

人工智能和分析技术在诊断成像中的日益普及无疑为多模式成像市场创造了令人兴奋的机会。通过释放复杂数据的力量，人工智能有可能改变我们诊断和治疗疾病的方式，从而改善患者的预后和更有效的医疗保健系统。

However, navigating the ethical and regulatory landscape alongside ensuring responsible development will be critical in realizing the full potential of this transformative technology..

然而，在道德和监管环境中导航，同时确保负责任的发展，对于实现这一变革性技术的全部潜力至关重要。。

Multimodal Molecular Imaging in Drug Discovery and Development

药物发现和开发中的多模式分子成像

The quest for faster, more efficient, and personalized drug development has led to the emergence of exciting new technologies. Among these, multimodal molecular imaging stands out as a game-changer, revolutionizing the way of visualizing and understanding diseases, ultimately shaping the future of pharmaceutical innovation, and paving the way for a booming multimodal imaging market.

对更快，更有效和个性化药物开发的追求导致了令人兴奋的新技术的出现。其中，多模式分子成像作为游戏规则的改变者脱颖而出，彻底改变了可视化和理解疾病的方式，最终塑造了药物创新的未来，并为蓬勃发展的多模式成像市场铺平了道路。

Multimodal imaging overcomes this limitation by seamlessly integrating data from multiple imaging modalities, such as PET, MRI, CT, and ultrasound, into a comprehensive picture..

多模式成像通过将来自多种成像模式（如PET，MRI，CT和超声波）的数据无缝集成到一张全面的图片中，克服了这一局限性。。

Growing Geriatric Population & Subsequent Rise in Chronic Conditions

不断增长的老年人口和随后的慢性病上升

Multimodal imaging, the synergistic combination of two or more imaging modalities like PET, MRI, and CT, offers a multifaceted solution to the diagnostic challenges posed by chronic diseases in aging populations. Each modality provides a unique perspective, revealing anatomical structures and functional processes.

多模式成像是两种或两种以上成像模式（如PET，MRI和CT）的协同组合，为老年人群慢性疾病带来的诊断挑战提供了多方面的解决方案。每种模式都提供了独特的视角，揭示了解剖结构和功能过程。

The growing need for advanced diagnostics in the face of rising chronic disease prevalence among older adults propels the multimodal imaging market forward. Industry analysts anticipate a significant rise in market value..

面对老年人慢性病患病率不断上升，对高级诊断的需求日益增长，推动了多模式成像市场的发展。行业分析师预计市场价值将大幅上升。。

Technological Advancements in Diagnostics Imaging Modalities

诊断成像模式的技术进步

The healthcare landscape is witnessing a pivotal shift towards personalized medicine, demanding ever-more accurate and comprehensive diagnostic tools. The scope of multimodal imaging is where technological advancements in individual imaging modalities are shaping their markets and fueling the explosive growth of a combined force.

医疗保健领域正在经历向个性化医疗的关键转变，需要更准确和全面的诊断工具。多模式成像的范围是，单个成像模式的技术进步正在塑造其市场，并推动联合部队的爆炸性增长。

Integrated scanners combining two or more modalities, like PET/CT or PET/MRI, offer one-stop solutions, streamlining workflows and reducing patient discomfort. Combining information from various modalities gives clinicians a more comprehensive view of disease, leading to earlier and more accurate diagnoses and ultimately improving patient outcomes..

结合两种或两种以上模式（如PET/CT或PET/MRI）的集成扫描仪提供了一站式解决方案，简化了工作流程并减少了患者的不适感。结合各种方式的信息，临床医生可以更全面地了解疾病，从而更早，更准确地诊断并最终改善患者预后。。

Recent Developments & Partnerships in the Multimodal Imaging Industry

多模式成像行业的最新发展和合作伙伴关系

The multimodal imaging market, fueled by the convergence of diverse imaging modalities, is undergoing a period of rapid evolution. Recent developments and strategic partnerships are pushing the boundaries of technology and propelling the market toward broader adoption and impactful applications. Collaborations between pharmaceutical and imaging companies accelerate drug development by utilizing multimodal imaging for early disease detection, target validation, and therapy monitoring.

在多种成像模式融合的推动下，多模式成像市场正在经历一个快速发展的时期。最近的发展和战略伙伴关系正在推动技术的界限，推动市场走向更广泛的采用和有影响力的应用。制药公司和成像公司之间的合作通过利用多模式成像进行早期疾病检测，靶标验证和治疗监测来加速药物开发。

Research institutions and industry players collaborate to translate innovative imaging technologies into clinical practice..

研究机构和行业参与者合作将创新的成像技术转化为临床实践。。

SEGMENTATION INSIGHTS

细分见解

INSIGHTS BY TECHNOLOGY

技术见解

The global multimodal imaging market is segmented based on technology into PET/CT, PET/MR, SPECT/CT, OCT/FMT, and others. The PET/CT accounted for the largest market in 2023. PET utilizes radiopharmaceuticals to detect metabolic activity within tissues, aiding in diagnosing and staging cancers, neurological disorders, and cardiovascular diseases.

全球多模式成像市场根据技术分为PET/CT，PET/MR，SPECT/CT，OCT/FMT等。2023年，PET/CT占据了最大的市场。PET利用放射性药物检测组织内的代谢活动，有助于诊断和分期癌症，神经系统疾病和心血管疾病。

CT offers detailed anatomical information, facilitating the localization and characterization of abnormalities detected on PET scans. PET/CT is widely used in oncology for tumor detection, staging, treatment planning, and response assessment, as well as in cardiology and neurology..

CT提供了详细的解剖信息，有助于PET扫描中检测到的异常的定位和表征。PET/CT广泛用于肿瘤学，用于肿瘤检测，分期，治疗计划和反应评估，以及心脏病学和神经病学。。

PET/MR offers advantages over PET/CT, including improved soft tissue contrast, reduced radiation exposure, and potential synergistic effects between PET and MRI. PET/MR is utilized in oncology, neurology, and cardiology for applications such as tumor imaging, neurodegenerative disease assessment, and myocardial perfusion imaging.

PET/MR比PET/CT具有优势，包括改善软组织对比度，减少辐射暴露以及PET和MRI之间潜在的协同作用。PET/MR用于肿瘤学，神经病学和心脏病学，用于肿瘤成像，神经退行性疾病评估和心肌灌注成像。

SPECT/CT integrates the functional imaging capabilities of SPECT with the anatomical imaging provided by CT. SPECT/CT is used in nuclear medicine for myocardial perfusion imaging, bone scans, thyroid imaging, and oncological applications. OCT/FMT is applied in ophthalmology for retinal imaging and angiography and in oncology for preclinical research and drug development..

SPECT/CT将SPECT的功能成像能力与CT提供的解剖成像相结合。SPECT/CT在核医学中用于心肌灌注成像，骨骼扫描，甲状腺成像和肿瘤学应用。OCT/FMT在眼科用于视网膜成像和血管造影，在肿瘤学中用于临床前研究和药物开发。。

INSIGHTS BY APPLICATION

按应用程序列出的见解

The global multimodal imaging market encompasses various diagnostic and clinical applications and applications in biomedical research. From brain & neurology and cardiology to oncology, ophthalmology, obstetrics and gynecology, and beyond, multimodal imaging is pivotal in advancing medical diagnostics, treatment planning, and research across various medical specialties..

全球多模式成像市场涵盖了生物医学研究中的各种诊断和临床应用以及应用。从脑与神经病学和心脏病学到肿瘤学、眼科、妇产科等，多模式成像在推进各种医学专业的医学诊断、治疗计划和研究方面至关重要。。

Multimodal imaging techniques such as MRI, CT, PET, SPECT, and fMRI are used for the diagnosis and treatment planning of neurological disorders such as stroke, brain tumors, epilepsy, and neurodegenerative diseases. MRI, CT, ultrasound, and molecular imaging are also utilized to assess tumor microstructure, vascularity, and metabolism, guiding personalized treatment approaches and monitoring disease progression.

MRI，CT，PET，SPECT和fMRI等多模式成像技术用于中风，脑肿瘤，癫痫和神经退行性疾病等神经系统疾病的诊断和治疗计划。MRI，CT，超声和分子成像也被用于评估肿瘤的微观结构，血管分布和代谢，指导个性化治疗方法和监测疾病进展。

In cardiology, multimodal imaging assesses cardiac structure, function, perfusion, and viability. Techniques such as PET/CT, PET/MRI, echocardiography, cardiac MRI, and coronary CT angiography are utilized to diagnose and manage cardiovascular diseases, including coronary artery disease, heart failure, valvular disorders, and cardiomyopathies..

在心脏病学中，多模式成像评估心脏结构，功能，灌注和活力。PET/CT，PET/MRI，超声心动图，心脏MRI和冠状动脉CT血管造影等技术用于诊断和管理心血管疾病，包括冠状动脉疾病，心力衰竭，瓣膜疾病和心肌病。。

INSIGHTS BY END-USER

最终用户见解

The global multimodal imaging market encompasses various end-users, including hospitals, diagnostic imaging centers, research institutions, and others. Each end-user segment contributes uniquely to the market's growth and evolution, fueling demand for advanced multimodal imaging technologies and applications across different medical diagnostics and research domains..

全球多模式成像市场涵盖了各种最终用户，包括医院、诊断成像中心、研究机构等。每个最终用户细分市场都为市场的增长和发展做出了独特的贡献，推动了对不同医学诊断和研究领域的先进多模式成像技术和应用的需求。。

Hospitals represent the largest end-user segment in the global multimodal imaging market. These facilities utilize multimodal imaging systems for diagnostic and therapeutic applications across various medical specialties, including radiology, neurology, cardiology, oncology, ophthalmology, and orthopedics.

医院代表了全球多模式成像市场中最大的最终用户细分市场。这些设施利用多模式成像系统在各种医学专业（包括放射学，神经病学，心脏病学，肿瘤学，眼科和骨科）进行诊断和治疗应用。

Diagnostic imaging centers are specialized facilities that provide various imaging services to patients referred by healthcare providers. These centers offer advanced multimodal imaging techniques such as MRI, CT, PET, SPECT, ultrasound, and nuclear medicine imaging. Diagnostic imaging centers are vital in early disease detection, screening, and monitoring, serving as important end-users in the multimodal imaging market..

诊断成像中心是为医疗保健提供者转诊的患者提供各种成像服务的专业设施。这些中心提供先进的多模式成像技术，如MRI、CT、PET、SPECT、超声波和核医学成像。诊断成像中心在早期疾病检测、筛查和监测中至关重要，是多模式成像市场的重要最终用户。。

KEY QUESTIONS ANSWERED

回答的关键问题

How big is the global multimodal imaging market?

全球多模式成像市场有多大？

What is the growth rate of the global multimodal imaging market?

全球多模式成像市场的增长率是多少？

Which region dominates the global multimodal imaging market share?

哪个地区主导着全球多模式成像市场份额？

What are the significant trends in the global multimodal imaging market?

全球多模式成像市场的重要趋势是什么？

Who are the key players in the global multimodal imaging market?

谁是全球多模式成像市场的关键参与者？

Key Attributes:

关键属性：

Report Attribute

报表属性

Details

详细信息

No. of Pages

页数

341

341

Forecast Period

预测期

2023 - 2029

2023 - 2029

Estimated Market Value (USD) in 2023

2023年估计市值（美元）

$4.02 Billion

40.2亿美元

Forecasted Market Value (USD) by 2029

2029年预测市场价值（美元）

$5.5 Billion

55亿美元

Compound Annual Growth Rate

年均复合增长率

5.3%

5.3%

Regions Covered

覆盖的区域

Global

全球

Market Opportunities & Trends

市场机遇与趋势

Growing Adoption of AI & Analytics in Diagnostic Imaging

人工智能和分析技术在诊断成像中的应用日益广泛

Multimodal Molecular Imaging in Drug Discovery and Development

药物发现和开发中的多模式分子成像

Availability of Reimbursement and Insurance Coverage for Scans

扫描报销和保险范围的可用性

Market Growth Enablers

市场增长促进因素

Growing Geriatric Population and Subsequent Rise in Chronic Conditions

老年人口的增长和随后慢性病的增加

Technological Advancements in Diagnostics Imaging Modalities

诊断成像模式的技术进步

Recent Developments & Partnerships in Multimodal Imaging Industry

多模式成像行业的最新发展和合作伙伴关系

Non-Invasive Imaging Fueling Growth in Neuroscience & Oncology Application

无创成像促进神经科学和肿瘤学应用的发展

Market Restraints

市场约束

High Operating Cost of Imaging Systems

成像系统的高运营成本

Growing Preference for Refurbished Equipment

对翻新设备的偏好日益增加

Lack of Skilled Professionals

缺乏熟练的专业人员

Key Company Profiles

主要公司简介

Canon Medical Systems

佳能医疗系统

GE Healthcare

GE Healthcare

Koninklijke Philips

皇家飞利浦

Shimadzu Corporation

日本岛津制作所

Siemens Healthineers

西门子Healthineers

Other Prominent Vendors

其他知名供应商

Bruker

使用者

Mediso

中等的

MILabs B.V.

MILabs B.V。

MinFound Medical Systems

MinFound医疗系统

MR Solution

MR解决方案

Shanghai United Imaging Healthcare

上海联合影像医疗

SOFIE

苏菲

Spectrum Dynamics Medical

频谱动力学医学

Topcon

特强

For more information about this report visit https://www.researchandmarkets.com/r/l262i7

有关此报告的更多信息，请访问https://www.researchandmarkets.com/r/l262i7

About ResearchAndMarkets.com

关于ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com是全球领先的国际市场研究报告和市场数据来源。我们为您提供有关国际和地区市场、关键行业、顶尖公司、新产品和最新趋势的最新数据。